By combining the Michaelis-Menten kinetics of metabolism with the two-stage model of Moolgavkar and Knudson (1981) and the extended two-stage model of carcinogenesis proposed by Tan and Gastardo (1985) , this paper proceeds to investigate the effects of metabolism of carcinogens on cancer tumor development. It is shown that the nonlinear kinetics of metabolism of carcinogens affect the dose-response relationship mainly through the mutation rates. If the initiator is affected by metabolism, then the metabolism of promoters has very little or negligible effects of the expected incidences and the number of tumors.
Introduction
In assessing effects ofenvironmental agents on cancer development, it is important to note that the biological dose inside the cell is quite different from the exposure dose, and it is the biological dose that is directly responsible for cancer development. For example, Hoel, Kaplan, and Anderson (1) have shown that it is not the exposed dose but the DNA adduct of agents that gives a linear dose-response curve for small doses. By using Michaelis-Menten kinetics, Van Ryzin and Rai (2) To provide a mathematical description of the carcinogenic process which can be used to interpret the results of experimental animal and human epidemiologic studies, Moolgavkar and Venzon (5) and Moolgavkar and Knudson (6) proposed a two-stage model of carcinogenesis. They modeled only two stages because no more than two distinct stages have been experimentally demonstrated. This model assumes that a malignant tumor develops from a normal stem cell after two cellular changes such as activation of cellular oncogenes; it dif-fers from the commonly used Armitage-Doll multistage model (7, 8) in that the two-stage model includes stochastic birth and death processes to describe cell proliferation and differentiation of both normal stem cells and premalignant initiated cells (i.e., cells that have undergone only the first cellular change). By assuming different tissue growth patterns, Moolgavkar and Knudson (6) showed their model could fit incidence curves of all human cancers, while the Armitage-Doll model could only fit most tumors of adult onset. In addtion, Moolgavkar (9) and Tan and Gastardo (10) have shown that the Moolgavkar-Venzon-Knudson (MVK) two-stage model provides an explanation for the results of initiation-promotion animal carcinogenesis experiments, the initiator affecting the rate of occurrence of the first cellular change and the promoter affecting the proliferation rates of the initiated cells. The discovery of antioncogenes (11) provides biological support for the MVK model. As noted by Moolgavkar (12) , pedigree analyses have shown that human cancers in some families are transmitted in an autosomal-dominant fashion.
Cytogenetic analyses of these hereditary cancers have revealed that particular genes are deleted. Thus, in contrast to oncogenes, it is the inactivation of these antioncogenes that leads to malignancy. Examples of antioncogenes include the retinoblastomas rb gene on chromosome 13 (13) (14) (15) and the Wilm's tumor wm gene on chromosome llp (16) (17) (18) .
Since it is definitely desirable to use biologically supported models of careinogenesis to perform risk assessments of carcinogens, in this paper, we proceed to assess effects of metabolism of environmental agents by combining the Michaelis-Menten kinetics of metabolism of carcinogens with the two-stage model of Moolgavkar and Knudson (6) and the extended two-stage model of Tan and Gastardo (10) .
Nonlinear Kinetics of Metabolism of Carcinogens and Carcinogenesis
As a well-documented example, it has been observed that mouse skin, when first treated by an initiator such as 7,12-dimethylbenz[a]anthracene (DMBA) and then followed by a promoter such as 12-O-tetradecanoylphorbol-13-acetate (TPA), gives rise to papillomas that may further progress with a very low rate of conversion to yield squamous cell carcinomas (malignant conversion) (19) ; however, Hennings et al. (20) reported that initiators such as N-methyl-N'-nitro-N-nitroso-guanidine (MNNG) or 4-nitroquinoline-N-oxide (r-QO), but not promoters, would induce carcinomas from papillomas. These results suggest different effects of metabolism of initiators and promoters. In terms of the twostage model of Moolgavkar and Knudson (6) , initiators are associated with the mutation rates, while promoters are related to proliferation and differentiation rate of initiated cells.
Effects of Metabolism of Carcinogens That Are Initiators
To initiate carcinogenesis, carcinogens are first converted metabolically into chemically reactive forms that bind covalently to DNA adducts, leading to DNA lesions. The DNA lesions may be repaired (normal), or not repaired (die), or mismatched repaired, which leads to mutations (21) . Recent experimental results of molecular biology have confirmed this theory for initiation of carcinogenesis. For example, Zarbl, Sukumar, and Barbacid (22) reported that, by injecting nitrosomethylurea (NMU) into the breast of female rats, NMU binds with DNA. Such a binding induces a G (guanine) to A (adenine) base transition at codon 12 of the ras gene, thus initiating the carcinogenesis process (initiation process).
To assess effects of metabolism of a carcinogen that is an initiator, we let C, M, and DM denote the carcinogen, the chemically activated metabolite of C and the DNA adduct, respectively. As illustrated in Gehring and Blau (23) 
Effects of Metabolism of Carcinogens That Are Promoters
The exact mechanism of how promoters increase cell proliferation remains illusive. However, a rough picture painted by molecular biologists seems to suggest that promoters facilitate the release of active oxygen species (2, HO, 02*, and H202) or free radicals or organic peroxides and their degradation products, which may mediate the induction of poly (ADP)-ribosylation of nuclear proteins for cell proliferation and macromolecular synthesis (24) (25) (26) (27) . For these electrophilic processes and/ or enzymatic processes, one may again assume Michaelis-Menten kinetics. Assuming first-order kinetics for detoxication processes and other elimination processes, the exposed dose [C] is then related to the biological dose [B] by [B] [C], where -y and 8 are constants that are functions of Michaelis-Menton constants, detoxication rates, and rates of other eliminating processes.
Let b1-dl be the difference between cell proliferation rate and cell differentiation rate of initiated cells. The above results then suggest that b1
, where is a constant, (2) and b -d is the natural background difference of cell proliferation rate and cell differentiation rate ofinitiated cells.
Assessing Effects of Metabolism of Carcinogens by a Two-Stage Model of Carcinogenesis
In this section we illustrate how to use the two-stage model of Moolgavkar and Knudson (6) and the extended model of Tan and Gastardo (10) to assess effects of metabolism of carcinogens on cancer tumor development. Specifically, we shall illustrate how the metabolism of carcinogens affects the expected incidence rate and the expected number of tumors by using the two-stage models of Moolgavkar and Knudson (6) and the extended two-stage model of Tan and Gastardo (10) . Note that the Tan-Gastardo extended model appears to provide a realistic model for many human cancers, including, for example, breast and ovary cancers (28) . This is expected, since for breast and ovary cancers, hormone (estrogen) levels are different over different time intervals, so that menarche, menopause, and the time of first pregnancy provide natural partitions of the lifetime interval.
Assessing Effects of Metabolism by the Two-Stage Model of Moolgavkar and Knudson
Let the first and second mutation rates be ao1 and t2, Then, for small a2j, the expected incidence X(tk) at t = tk is given approximately by: Table 1 parameter values for the above two cases. Note that for case 2, we considered only the situations of initation and initiation followed by promotion; we did not present situations of promotion only because effects of promotion are negligible if initiator is not applied before promotion (9, 10, 37 
